- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Marksans Pharma Share Price
Marksans Pharma Ltd.
₹197.50
Invest in MARKSANS with up to 2.22x margin.
Trade with MTFMarksans Pharma Performance
Price Movement
₹197.22
₹205.90
1 Year Performance
₹155.00
₹270.70
Markets Today
Historical Performance
Marksans Pharma Fundamentals
Marksans Pharma Financials
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 339.73 | 320.44 | 319.73 | 299.36 | 311.86 |
| Operating Expense | 264.28 | 248.37 | 249.68 | 248.78 | 251.92 |
| Operating Profit | 75.44 | 72.08 | 70.05 | 50.57 | 59.94 |
| Depreciation | 8.83 | 8.46 | 8.19 | 8.18 | 7.42 |
| Interest | 0.36 | 0.32 | 0.30 | 0.31 | 0.30 |
| Tax | 21.20 | 21.69 | 15.52 | 12.31 | 19.26 |
| Net Profit | 60.91 | 99.81 | 48.06 | 37.59 | 55.46 |
Marksans Pharma Technicals
Marksans Pharma Ltd. EMA & SMA
₹197.50
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
Marksans Pharma Support and Resistance
Resistance
Support
Technical Indicators
Marksans Pharma Shareholding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 43.9 | 43.9 | 43.9 | 43.9 | 43.9 | 43.9 |
| FII | 22 | 22.2 | 19.9 | 16.9 | 8.1 | 16.8 |
| DII | 4.2 | 4.5 | 5.5 | 5.3 | 5.9 | 6.5 |
| Public | 29.9 | 29.4 | 30.7 | 33.9 | 42.1 | 32.8 |
Marksans Pharma Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 10.23 L | 28.24 L | 36.21% |
| Week | 10.92 L | 34.44 L | 31.71% |
| 1 Month | 5.36 L | 14.73 L | 36.37% |
| 6 Month | 4.02 L | 9.26 L | 43.41% |
Marksans Pharma SWOT Analysis
Benjamin Graham Value Screen
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Increasing profits every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter
Marksans Pharma Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 01 Aug, 2025 | 0.8 | FINAL | 01 Aug, 2025 | Equity Share |
| 17 Sep, 2024 | 0.6 | FINAL | 17 Sep, 2024 | Equity Share |
| 07 Jun, 2023 | 0.5 | FINAL | 07 Jun, 2023 | Equity Share |
| 19 Aug, 2022 | 0.25 | FINAL | Equity Share | |
| 15 Sep, 2021 | 0.25 | FINAL | Equity Share | |
| 22 Sep, 2020 | 0.1 | FINAL | Equity Share | |
| 19 Sep, 2019 | 0.05 | FINAL | Equity Share | |
| 19 Sep, 2018 | 0.05 | FINAL | Equity Share | |
| 19 Sep, 2017 | 0.05 | FINAL | Equity Share | |
| 22 Sep, 2016 | 0.12 | FINAL | Equity Share |
Marksans Pharma Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,685.20 | ₹660 | ₹950 | ₹4,775 | ₹558.05 | ₹491 |
| % Change | -3.31% | -1.83% | -0.14% | 0.30% | 1.83% | 0.13% |
| Revenue TTM (₹ Cr) | - | - | ₹1,598.19 | ₹935 | ₹4,256.70 | ₹1,053.10 |
| Net Profit TTM (₹ Cr) | - | - | ₹206.20 | ₹257.90 | ₹318.19 | ₹293.57 |
| PE TTM | - | - | 76.50 | 42.60 | 27.60 | 29.00 |
| 1 Year Return | 61.23 | 10.96 | 97.07 | -3.76 | 8.77 | -33.56 |
| ROCE | 30.24 | 34.78 | 34.76 | - | 11.27 | 52.32 |
Similar Stocks
CONCORDBIO
Concord Biotech Ltd.
₹ 1170.00
-2.39%
AARTIPHARM
Aarti Pharmalabs Ltd.
₹ 767.00
-1.37%
SUPRIYA
Supriya Lifescience Ltd.
₹ 705.00
+0.56%
ALIVUS
Alivus Life Sciences Ltd.
₹ 1120.10
-0.09%
COHANCE
Cohance Lifesciences Ltd.
₹ 487.90
+0.63%
ERIS
Eris Lifesciences Ltd.
₹ 1389.70
+0.47%
SYNGENE
Syngene International Ltd.
₹ 459.50
-1.68%
APLLTD
Alembic Pharmaceuticals Ltd.
₹ 783.00
+0.83%
SPARC
Sun Pharma Advanced Research Company Ltd.
₹ 173.01
+3.69%
STAR
Strides Pharma Science Ltd.
₹ 1169.00
+1.94%
GRANULES
Granules India Ltd.
₹ 750.10
+0.89%
FDC
FDC Ltd.
₹ 380.25
+1.25%
SHILPAMED
Shilpa Medicare Ltd.
₹ 434.00
-1.74%
JUBLPHARMA
Jubilant Pharmova Ltd.
₹ 1009.00
+2.84%
CAPLIPOINT
Caplin Point Laboratories Ltd.
₹ 1854.00
-0.68%
SANOFI
Sanofi India Ltd.
₹ 3332.90
-1.70%
PGHL
Procter & Gamble Health Ltd.
₹ 5368.00
+0.89%
JSLL
Jeena Sikho Lifecare Ltd.
₹ 748.00
+1.29%
FAQ's on MARKSANS
What is the current share price of Marksans Pharma Ltd.?
What is the Market Capitalization of Marksans Pharma Ltd.?
What are the PE and PB ratios for Marksans Pharma Ltd.?
What is the 52-Week High and Low for Marksans Pharma Ltd.?
What is the current dividend yield for Marksans Pharma Ltd.?
Who are the major shareholders of Marksans Pharma Ltd.?
- Promoter
- Public
- FII
- Mutual Funds
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Marksans Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Marksans Pharma Ltd.?
By signing up I certify terms, conditions & privacy policy